Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marta Ollé (Barcelona, Spain), Marta Ollé, Xavier Muñoz, Jokin Yllera, Mª Dolores Untoria, Daniel Álvarez, Mª Jesús Cruz. Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents. Eur Respir J 2016; 48: Suppl. 60, 4270

Member's Comments

No comment yet.

Related content which might interest you: Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma Source: International Congress 2016 – Immune responses in the lung Year: 2016 The effect of different PV extracts in the treatment of asthma in an animal model Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Low level laser in monotherapy or in combination with leukotriene receptor antagonists in the treatment of allergic lung inflammation Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Investigating antioxidant therapy for steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Characterisation of a steroid-insensitive severe asthma model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Developing a chronic murine model that better reflects the clinical features of the human asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Adjuvant-free mouse model of allergic asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Standardization of a murine model of asthma due to soybean inhalation Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice Source: International Congress 2014 – Asthma: clinical problems Year: 2014 A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Effects of prenatal tobacco smoke exposure on pulmonary signaling networks in a murine model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Exosomal microRNAs in the serum are potential real-time biomarkers for allergic inflammation in the airway of mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014